Home/Filings/4/0001214659-21-002803
4//SEC Filing

RAGUSA ROBERT P 4

Accession 0001214659-21-002803

CIK 0001581280other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:50 PM ET

Size

12.6 KB

Accession

0001214659-21-002803

Insider Transaction Report

Form 4
Period: 2021-03-03
Transactions
  • Sale

    Common Stock

    2021-03-03$132.15/sh2,299$303,82410,187 total
  • Sale

    Common Stock

    2021-03-03$134.04/sh1,770$237,2551,898 total
  • Exercise/Conversion

    Common Stock

    2021-03-03$30.41/sh+10,588$321,98112,486 total
  • Sale

    Common Stock

    2021-03-03$133.10/sh6,519$867,6663,668 total
  • Exercise/Conversion

    Director Stock Option (right to buy)

    2021-03-0310,5880 total
    Exercise: $30.41Exp: 2029-07-22Common Stock (10,588 underlying)
Footnotes (4)
  • [F1]Represents the weighted average sales price per share. The shares sold at prices ranging from $131.44 to $132.37 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  • [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $132.59 to $133.56 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  • [F3]Represents the weighted average sales price per share. The shares sold at prices ranging from $133.61 to $134.47 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  • [F4]100% of the shares subject to the option vested and became exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.

Issuer

Twist Bioscience Corp

CIK 0001581280

Entity typeother

Related Parties

1
  • filerCIK 0001222644

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:50 PM ET
Size
12.6 KB